Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0067 | 0.2644 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0074 | 0.3084 | 0.2927 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0193 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0193 | 1 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 0.2478 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0067 | 0.2644 | 0.0957 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0032 | 0.0586 | 0.0373 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0067 | 0.2644 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0067 | 0.2644 | 0.0957 |
Plasmodium vivax | glutathione reductase, putative | 0.0193 | 1 | 1 |
Schistosoma mansoni | flap endonuclease-1 | 0.0023 | 0.0079 | 0.0079 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0067 | 0.2644 | 0.2478 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0582 | 0.0582 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0067 | 0.2644 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0032 | 0.0586 | 0.0373 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0067 | 0.2644 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0067 | 0.2644 | 0.2478 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0032 | 0.0586 | 0.0586 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0193 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0067 | 0.2644 | 0.5 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0067 | 0.2644 | 0.2478 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0025 | 0.0221 | 0.0221 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0067 | 0.2644 | 0.2478 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0067 | 0.2644 | 0.0957 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0067 | 0.2644 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0067 | 0.2644 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0032 | 0.0582 | 0.0582 |
Brugia malayi | Thioredoxin reductase | 0.0193 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0193 | 1 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0067 | 0.2644 | 0.2478 |
Plasmodium falciparum | glutathione reductase | 0.0067 | 0.2644 | 0.2478 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0193 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0193 | 1 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0049 | 0.1609 | 0.1609 |
Treponema pallidum | NADH oxidase | 0.0067 | 0.2644 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0067 | 0.2644 | 0.2478 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0032 | 0.0582 | 0.0582 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 0.2478 |
Plasmodium falciparum | thioredoxin reductase | 0.0067 | 0.2644 | 0.2478 |
Brugia malayi | Flap endonuclease-1 | 0.0025 | 0.0221 | 0.0221 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0067 | 0.2644 | 0.2478 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 0.2644 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0193 | 1 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0074 | 0.3084 | 0.2927 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Loa Loa (eye worm) | glutathione reductase | 0.0193 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0049 | 0.1609 | 0.1609 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0067 | 0.2644 | 0.2478 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0067 | 0.2644 | 0.2478 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0032 | 0.0582 | 0.0582 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0067 | 0.2644 | 0.2644 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 0.2478 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0067 | 0.2644 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0074 | 0.3084 | 0.2927 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0067 | 0.2644 | 0.0957 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Echinococcus granulosus | glutamate receptor 2 | 0.0032 | 0.0586 | 0.0373 |
Entamoeba histolytica | Flap nuclease, putative | 0.0025 | 0.0221 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0193 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0193 | 1 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0067 | 0.2644 | 0.2478 |
Leishmania major | trypanothione reductase | 0.0193 | 1 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0067 | 0.2644 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0067 | 0.2644 | 0.2478 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0067 | 0.2644 | 0.2478 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0032 | 0.0586 | 0.0373 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0193 | 1 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0032 | 0.0586 | 0.0373 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.